| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000225439.2 |
Gefitinib |
Lung squamous cell carcinoma |
0.031927902 |
Resistant |
| ENSG00000225439.2 |
Gefitinib |
Stomach adenocarcinoma |
0.015890484 |
Resistant |
| ENSG00000225439.2 |
Gefitinib |
Pancreatic adenocarcinoma |
0.045799902 |
Sensitive |
